C
Charles D. Mitchell
Researcher at University of Miami
Publications - 85
Citations - 3733
Charles D. Mitchell is an academic researcher from University of Miami. The author has contributed to research in topics: Population & Tuberculosis. The author has an hindex of 31, co-authored 84 publications receiving 3517 citations. Previous affiliations of Charles D. Mitchell include University of Minnesota & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Survival in children with perinatally acquired human immunodeficiency virus type 1 infection.
Gwendolyn B. Scott,Cecelia Hutto,Robert W. Makuch,Mary T. Mastrucci,Theresa Z. O'Connor,Charles D. Mitchell,Edward J. Trapido,Wade P. Parks +7 more
TL;DR: The experience at Jackson Memorial Hospital in Miami, Florida, with 172 children who were given diagnoses of perinatally acquired infection with human immunodeficiency virus ty... is described.
Journal ArticleDOI
Evaluation of Tuberculosis Diagnostics in Children: 1. Proposed Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease. Consensus From an Expert Panel
Stephen M. Graham,Stephen M. Graham,Tahmeed Ahmed,Farhana Amanullah,Renee Browning,Vicky Cárdenas,Martina Casenghi,Luis E. Cuevas,Marianne Gale,Robert P. Gie,M. Grzemska,Ed Handelsman,Mark Hatherill,Anneke C. Hesseling,Patrick Jean-Philippe,Beate Kampmann,Beate Kampmann,Sushil K. Kabra,Christian Lienhardt,Jennifer Lighter-Fisher,Shabir A. Madhi,Mamodikoe Makhene,Ben J. Marais,David F. McNeeley,Heather J. Menzies,Charles D. Mitchell,Surbhi Modi,Lynne M. Mofenson,Philippa Musoke,Sharon Nachman,Clydette Powell,Mona Rigaud,Vanessa Rouzier,Jeffrey R. Starke,Soumya Swaminathan,Claire Wingfield +35 more
TL;DR: The definitions presented in this article are intended for use in clinical research to evaluate diagnostic assays and not for individual patient diagnosis or treatment decisions.
Journal ArticleDOI
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
Joel D. Meyers,James C. Wade,Charles D. Mitchell,Rein Saral,Paul S. Lietman,David T. Durack,Myron J. Levin,Anthony C. Segreti,Henry H. Balfour +8 more
TL;DR: The most common adverse reaction was a low incidence of peripheral vein irritation; no serious toxicity could be definitely attributed to acyclovir treatment even in these seriously ill patients.
Journal ArticleDOI
Renal disease in children with the acquired immunodeficiency syndrome.
Jose Strauss,Carolyn Abitbol,Gaston Zilleruelo,Gwendolyn B. Scott,Ana Paredes,Serafin Malaga,Brenda Montane,Charles D. Mitchell,Wade P. Parks,Victoriano Pardo +9 more
TL;DR: Of 155 children with the acquired immunodeficiency syndrome (AIDS) whom the authors evaluated during a 6 1/2-year period, 12 were found to have proteinuria, and 10 of the 12 patients with proteinuria died during this period.
Journal ArticleDOI
Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients
Charles D. Mitchell,Sharron R. Gentry,James R. Boen,Bonnie Bean,Karl E. Groth,Henry H. Balfour +5 more
TL;DR: Acyclovir seems to be a non-toxic and effective treatment for mucocutaneous herpes simplex virus infections in immunocompromised patients.